Allianz Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,900
| Closed | -$387K | – | 1705 |
|
|
2025
Q1 | $387K | Hold |
9,900
| – | – | ﹤0.01% | 1495 |
|
|
2024
Q4 | $536K | Buy |
9,900
+4,700
| +90% | +$255K | ﹤0.01% | 1396 |
|
|
2024
Q3 | $262K | Sell |
5,200
-7,100
| -58% | -$358K | ﹤0.01% | 1564 |
|
|
2024
Q2 | $541K | Hold |
12,300
| – | – | ﹤0.01% | 1400 |
|
|
2024
Q1 | $618K | Hold |
12,300
| – | – | ﹤0.01% | 1359 |
|
|
2023
Q4 | $743K | Buy |
12,300
+4,200
| +52% | +$254K | ﹤0.01% | 1307 |
|
|
2023
Q3 | $462K | Buy |
8,100
+3,700
| +84% | +$211K | ﹤0.01% | 1462 |
|
|
2023
Q2 | $224 | Buy |
+4,400
| New | +$224 | ﹤0.01% | 1639 |
|